New York, NY -- (SBWIRE) -- 12/20/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Sansiri Public Company Limited (BKK:SIRI), Rite Aid Corporation (NYSE:RAD), Ariad Pharmaceuticals, Inc (NASDAQ:ARIA), Annaly Capital Management, Inc (NYSE:NLY)
Sansiri Public Company Limited (BKK:SIRI) the stock opened the session at $1.78 but then moved to $1.84. At that price, the stock showed a positive performance of 3.37%. Sansiri Public Company Limited is a Thailand-based company engaged in the real estate business. The Company is principally engaged in property development with its properties consisting of land and housing projects under the brands: Sansiri, Setsiri, and Saransiri, among others, residential condominium projects, serviced apartments for rent,
Will SIRI Continue To Move Higher? Find Out Here
Rite Aid Corporation (NYSE:RAD) opened the session at $5.43 and closed the session at $5.17. The stock showed a negative performance of -10.24% in previous trading session. Rite Aid Corporation is a retail drugstore chain in the United States. As of March 3, 2013, it operated 4,623 stores in 31 states across the country and in the District of Columbia. In the Company’s stores, it sells prescription drugs and a range of other merchandise, which it calls front end products. During the fiscal year ended March 3, 2013 (fiscal 2013), prescription drug sales accounted for 67.6% of its total sales.
Has RAD Found The Bottom And Ready To Gain Momentum? Find Out Here
Ariad Pharmaceuticals, Inc (NASDAQ:ARIA) opened the session at $4.98 and closed the session at $5.52. The stock showed a positive performance of 10.84% in previous trading session. The beta of the stock remained 0.81. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic,
Why Should Investors Buy ARIA After The Recent Gain? Just Go Here and Find Out
Annaly Capital Management, Inc (NYSE:NLY) the stock decreased -3.42% and finished the session at $9.87. Traded with volume of 29.21 million shares in the prior session and the average volume of the stock remained 15.97 million shares. The beta of the stock remained 0.31. Annaly Capital Management, Inc. (Annaly) owns, manage, and finance a portfolio of real estate related investments, including mortgage pass-through certificates, collateralized mortgage obligations (CMOs), Agency callable debentures, and other securities representing interests in or obligations backed by pools of mortgage loans. The Company's wholly owned subsidiaries offer diversified real estate, asset management and other financial services.
Will NLY Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)